Compositions and methods for treating elevated blood...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/405 (2006.01) A61K 31/12 (2006.01) A61K 31/21 (2006.01) A61K 31/221 (2006.01) A61K 31/35 (2006.01) A61K 31/351 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/44 (2006.01)

Patent

CA 2335366

The present invention relates to compositions and methods for treating elevated blood cholesterol in a mammal while counteracting the occurrence of potentially adverse side effects such as myopathy. The compositions useful herein comprise the combination of a pharmaceutically effective amount of a 3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitor ("HMG-CoA reductase inhibitor") and a geranylgeraniol compound to a mammal in need thereof.

L'invention concerne des compositions et des méthodes de traitement d'une cholestérolémie élevée chez un mammifère tout en évitant l'apparition d'effets secondaires indésirables tels que la myopathie. Ces compositions contiennent une combinaison d'une dose pharmaceutiquement efficace d'un inhibiteur de la 3-hydroxy-3-méthyl-glutaryle coenzyme A (HMG-CoA) réductase et d'un composé de géranylgéraniol. Ces compositions sont destinées à être administrées à un mammifère nécessitant un tel traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for treating elevated blood... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating elevated blood..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating elevated blood... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1581612

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.